MEF2D and precursor B-cell acute lymphoblastic leukemia: Recent studies have revealed that subtypes of B-ALL associated with poor prognosis, such as Ph-like ALL16–18, IKZF1-plus ALL19, and MEF2D-rearranged ALL20,21, comprise a substantial proportion of B-ALL in the NCI-HR category.